{"component": "definition", "props": {"groups": [{"samples": [{"hash": "dewJD8EEW8n", "uri": "https://www.hamilton.ca/sites/default/files/2025-02/21-021-consolidation-feb2025.pdf", "label": "www.hamilton.ca", "score": 19.0472812653, "published": false}, {"hash": "42Hy3vmC1a", "uri": "https://www.hamilton.ca/sites/default/files/2024-12/21-021-consolidation-dec2024.pdf", "label": "www.hamilton.ca", "score": 18.7333946228, "published": false}, {"hash": "ECMWVF3Yzj", "uri": "https://pub-hamilton.escribemeetings.com/filestream.ashx?DocumentId=253914", "label": "pub-hamilton.escribemeetings.com", "score": 15.7750205994, "published": false}], "snippet": "means to appeal a ruling of the Chair.", "snippet_links": [{"key": "the-chair", "type": "clause", "offset": [28, 37]}], "size": 21, "hash": "7c1d43d5dcf2241718fc435e87a52c46", "id": 1}, {"samples": [{"hash": "k8ooBQYnkkE", "uri": "https://cityofgp.com/sites/default/files/2022-10/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 17.7093009949, "published": false}, {"hash": "74JPzpShBFv", "uri": "https://cityofgp.com/sites/default/files/2022-11/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 17.6079540253, "published": false}, {"hash": "5q3IpctWaMo", "uri": "https://cityofgp.com/sites/default/files/2023-05/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 11.6652975082, "published": false}], "snippet": "means an appeal of a ruling of the Chair.", "snippet_links": [{"key": "an-appeal", "type": "clause", "offset": [6, 15]}, {"key": "the-chair", "type": "clause", "offset": [31, 40]}], "size": 12, "hash": "6fa0f9aaec4dd7e3fced350bae171d6c", "id": 2}, {"samples": [{"hash": "hTHrx0EV42k", "uri": "/contracts/hTHrx0EV42k#challenge", "label": "Research Collaboration Agreement (CytomX Therapeutics, Inc.)", "score": 26.7385349274, "published": true}, {"hash": "6aFf4JTjPSh", "uri": "/contracts/6aFf4JTjPSh#challenge", "label": "Research Collaboration Agreement (CytomX Therapeutics, Inc.)", "score": 26.7111568451, "published": true}, {"hash": "bjaLBpdoiWm", "uri": "/contracts/bjaLBpdoiWm#challenge", "label": "Research Collaboration Agreement (CytomX Therapeutics, Inc.)", "score": 26.6536617279, "published": true}], "snippet": "means any challenge to the [***], or [***] of any of the Licensed Patent Rights, including without limitation: (a) filing a declaratory judgment action in which any of the Licensed Patent Rights is alleged to be invalid or unenforceable; (b) citing prior art pursuant to 35 U.S.C. \u00a7122 or \u00a7301, filing a request for re-examination of any of the Licensed Patent Rights pursuant to 35 U.S.C. \u00a7302 or \u00a7311, filing [***] of the Licensed Patent Rights pursuant to [***], or filing [***] of the Licensed Patent Rights pursuant to [***]; or (c) filing or commencing any re-examination, opposition, cancellation, nullity or similar proceeding against any of the Licensed Patent Rights in any country.", "snippet_links": [{"key": "licensed-patent-rights", "type": "clause", "offset": [57, 79]}, {"key": "including-without-limitation", "type": "clause", "offset": [81, 109]}, {"key": "declaratory-judgment-action", "type": "clause", "offset": [124, 151]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [212, 236]}, {"key": "prior-art", "type": "clause", "offset": [249, 258]}, {"key": "pursuant-to", "type": "definition", "offset": [259, 270]}, {"key": "request-for-re", "type": "clause", "offset": [304, 318]}], "size": 11, "hash": "36310b17a29cb10774411a9a4b6e3d72", "id": 3}, {"samples": [{"hash": "aB8PvxczUGL", "uri": "https://archive.legmt.gov/bills/2023/AmdHtmS/SB0531.004.001.pdf", "label": "archive.legmt.gov", "score": 17.5181388855, "published": false}, {"hash": "5E00yxhG0BY", "uri": "https://archive.legmt.gov/bills/2023/AmdPublicWeb/SB0531.002.002_Amendments-in-Context_final-full.pdf", "label": "archive.legmt.gov", "score": 16.9909534454, "published": false}, {"hash": "3ZAu1A7znj4", "uri": "https://leg.mt.gov/bills/2023/billpdf/SB0531.pdf", "label": "leg.mt.gov", "score": 16.9503993988, "published": false}], "snippet": "means a contest to a proposal submitted to the department for funding on the", "snippet_links": [{"key": "a-proposal", "type": "clause", "offset": [19, 29]}, {"key": "the-department", "type": "clause", "offset": [43, 57]}, {"key": "for-funding", "type": "clause", "offset": [58, 69]}], "size": 10, "hash": "ed50f3749edff4034daf15a759968990", "id": 4}, {"samples": [{"hash": "58MMvN6N4qo", "uri": "/contracts/58MMvN6N4qo#challenge", "label": "License and Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "bq6qqJEYs6g", "uri": "/contracts/bq6qqJEYs6g#challenge", "label": "Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)", "score": 29.3641338348, "published": true}, {"hash": "7WuQDcjFFxx", "uri": "/contracts/7WuQDcjFFxx#challenge", "label": "License and Collaboration Agreement (Planet Alpha Corp.)", "score": 28.6824092865, "published": true}], "snippet": "shall have the meaning set forth in Section 12.4.", "snippet_links": [{"key": "section-124", "type": "clause", "offset": [36, 48]}], "size": 10, "hash": "603d597d2fab41614b6529d1ffe38051", "id": 5}, {"samples": [{"hash": "IExZOwDUzN", "uri": "/contracts/IExZOwDUzN#challenge", "label": "Partnership Agreement", "score": 31.3408622742, "published": true}, {"hash": "3hVkYw8XOuO", "uri": "/contracts/3hVkYw8XOuO#challenge", "label": "Partnership Agreement", "score": 31.3408622742, "published": true}, {"hash": "gKxCTRePZ0O", "uri": "/contracts/gKxCTRePZ0O#challenge", "label": "Partnership Agreement (Newmark Group, Inc.)", "score": 28.9644088745, "published": true}], "snippet": "has the meaning set forth in Section 13.19(a).", "snippet_links": [], "size": 9, "hash": "6f43b66ba8409fa9e819700fbf08d8d5", "id": 6}, {"samples": [{"hash": "k46JgD84wNT", "uri": "https://zimlii.org/akn/zw/act/2017/5/eng@2018-01-01/source.pdf", "label": "zimlii.org", "score": 18.8837432861, "published": false}, {"hash": "fGZAL7NM2rc", "uri": "https://zimlii.org/akn/zw/act/2017/5/eng@2020-02-07/source.pdf", "label": "zimlii.org", "score": 18.800151825, "published": false}, {"hash": "30IyKgzLTuH", "uri": "https://media.zimlii.org/files/legislation/akn-zw-act-2017-5-eng-2020-02-07.pdf", "label": "media.zimlii.org", "score": 11.1793289185, "published": false}], "snippet": "means a challenge to procurement proceedings brought in terms of Part X;", "snippet_links": [{"key": "procurement-proceedings", "type": "definition", "offset": [21, 44]}, {"key": "terms-of", "type": "clause", "offset": [56, 64]}], "size": 8, "hash": "9db257bd4b32d4b297352cfb1d5ed423", "id": 7}, {"samples": [{"hash": "lsSVu1S280r", "uri": "https://www.legis.iowa.gov/docs/iac/agency/02-01-2017.751.pdf", "label": "www.legis.iowa.gov", "score": 9.2740497589, "published": false}, {"hash": "b6g1IYjCUTm", "uri": "https://www.legis.iowa.gov/docs/iac/agency/02-26-2020.751.pdf", "label": "www.legis.iowa.gov", "score": 7.308008194, "published": false}, {"hash": "lsSVu1S280r", "uri": "https://www.legis.iowa.gov/docs/iac/agency/07-04-2018.751.pdf", "label": "www.legis.iowa.gov", "score": 6.1375770569, "published": false}], "snippet": "means a dispute regarding a scheduled and validated video session.", "snippet_links": [{"key": "a-dispute", "type": "definition", "offset": [6, 15]}], "size": 8, "hash": "3094cbf5b058bdcffa37611366cbe19a", "id": 8}, {"samples": [{"hash": "gidcnacw4NY", "uri": "/contracts/gidcnacw4NY#challenge", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "iRvjqoHJzUC", "uri": "/contracts/iRvjqoHJzUC#challenge", "label": "Technology License and Collaboration Agreement (Aridis Pharmaceuticals, Inc.)", "score": 29.7337436676, "published": true}, {"hash": "7kgNqrhzqIu", "uri": "/contracts/7kgNqrhzqIu#challenge", "label": "Technology License and Collaboration Agreement (Aridis Pharmaceuticals, Inc.)", "score": 29.5420951843, "published": true}], "snippet": "means any challenge to the validity or enforceability of any of the Licensor Patents, including without limitation by (a) filing a declaratory judgment action in which any of the Licensor Patents is alleged to be invalid or unenforceable; or (b) filing or commencing any re-examination, interference, derivation proceeding, post-issuance proceeding, opposition, cancellation, nullity or similar proceedings against any of the Licensor Patents in the courts or patent offices in any country.", "snippet_links": [{"key": "licensor-patents", "type": "definition", "offset": [68, 84]}, {"key": "including-without-limitation", "type": "clause", "offset": [86, 114]}, {"key": "declaratory-judgment-action", "type": "clause", "offset": [131, 158]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [213, 237]}, {"key": "similar-proceedings", "type": "clause", "offset": [387, 406]}, {"key": "patent-offices", "type": "definition", "offset": [460, 474]}], "size": 8, "hash": "6081e2741d122ac6c83ee418ef881530", "id": 9}, {"samples": [{"hash": "3VwbcLDFrRS", "uri": "https://www.freit.org/WorkingPapers/Papers/Other/FREIT1786.pdf", "label": "www.freit.org", "score": 9.3846683502, "published": false}, {"hash": "gqzhiZzqoQV", "uri": "https://cpag.org.uk/sites/default/files/uploads/16-05%20Sanctions%20Stats%20Briefing%20-%20D%20Webster%2031%20May%202016.docx", "label": "cpag.org.uk", "score": 6.2142367363, "published": false}, {"hash": "igloijVbzPi", "uri": "https://www.rightsnet.org.uk/?ACT=39&fid=5&aid=1106_g4q3TyqS7SIuGvH6eA1D&board_id=1", "label": "www.rightsnet.org.uk", "score": 5.9582476616, "published": false}], "snippet": "means any challenge to a sanction decision, i.e. it embraces \u2018decision reviews\u2019, \u2018mandatory reconsiderations\u2019 and Tribunal appeals.", "snippet_links": [], "size": 7, "hash": "5f1e90cf339948b0248d82823502f8ab", "id": 10}], "next_curs": "ClYSUGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjILEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiISY2hhbGxlbmdlIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Challenge", "snippet": "means to appeal a ruling of the Chair.", "size": 502, "id": "challenge", "examples": ["For clarity, a Patent <strong>Challenge</strong> shall not include arguments made by Yarrow or any of its Affiliates that distinguish any Patent Right from those claimed in the Licensed Patent Rights in the ordinary course of ex parte prosecution as long as such distinguishment does not otherwise constitute any action described in the definition of Patent <strong>Challenge</strong>.", "If Licensee, its Affiliates or a Sublicensee institutes a <strong>Challenge</strong>, Ligand may, at its option, terminate this Agreement and revoke any rights and licenses herein with [***] prior written notice."], "related": [["contest", "Contest", "Contest"], ["complaint-investigation", "Complaint Investigation", "Complaint Investigation"], ["patent-challenge", "Patent Challenge", "Patent <strong>Challenge</strong>"], ["threatened-litigation", "Threatened litigation", "Threatened litigation"], ["legal-action", "Legal Action", "Legal Action"]], "related_snippets": [], "updated": "2026-04-02T05:49:26+00:00"}, "json": true, "cursor": ""}}